Long-term treatment and prevention of relapse of obsessive compulsive disorder with paroxetine

By Dunbar G.   Steiner M.   Bushnell W.D.   Gergel I.   Wheadon D.E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 372-372

Elsevier

Access to resources Recommend Favorite

5-HT 1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo

By Broocks A.   Meyer T.   Opitz M.   Bartmann U.   Hillmer-Vogel U.   George A.   Pekrun G.   Wedekind D.   Ruther E.   Bandelow B.  

European Neuropsychopharmacology, Vol. 13, Iss. 3, 2003-05 ,pp. : 153-164

Elsevier

Access to resources Recommend Favorite

Non-Antidepressant Pharmacologic Long-Term Treatment of Panic Disorder

By  

Current Clinical Pharmacology, Vol. 10, Iss. 2, 2015-01 ,pp. : 112-115

Bentham Science Publishers

Access to resources Recommend Favorite

Nocturnal Urinary Cortisol Excretion Over a Randomized Controlled Trial with Paroxetine vs. Placebo Combined with Relaxation Training or Aerobic Exercise in Panic Disorder

By  

Current Pharmaceutical Design, Vol. 14, Iss. 33, 2008-11 ,pp. : 3518-3524

Bentham Science Publishers

Access to resources Recommend Favorite

Panic disorder in the elderly may be associated with depression or other comorbid conditions and typically requires long-term treatment

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 9, 2004-09 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite